A Study Of Neurodevelopmental And Neuromusculoskeletal Controls

Overview

About this study

The purpose of this study is to identify specific potential biomarkers and therapeutic targets from patients with Cerebral Palsy by analyzing the number of EVs, cargo-proteomics, surface markers, whole genome/epigenetic markers of blood, and DNA methylation profiles of blood.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Between the ages of 2-30 with various neuromuscular or neurodevelopmental disorders

Exclusion Criteria:

  • Unable to Consent

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/24/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Joline Brandenburg, M.D.

Open for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions